Sanofi

NYSE

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Eli Lilly and Co.

Biotech

News

Eurozone

Health Care

General

VIGL

Un passo avanti nella lotta contro l&#39;Alzheimer. Analisi delle prospettive per la salute e per il mercato in seguito alle ultime decisioni.

Alzheimer: la mossa di Eli Lilly che fa sperare pazienti e investitori

Shanghai,,China,-,June,29,,2023:,Saic,Roewe,Feifan,F7

Tech

BPMC

CRDO

PSTV

SAIC

Tra utili societari, un&#39;acquisizione miliardaria e movimenti after-hours: alcune storie pronte a sfidare il trend di mercato.

Futures in rosso: 5 titoli sotto la lente d&#39;ingrandimento oggi

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

TSVT

VRTX

L&#39;analisi sui settori più volatili e le strategie per affrontare le incertezze: ecco i trend da seguire per proteggere il tuo portafoglio.

3 titoli che potrebbero non farti dormire sonni tranquilli

Sanofi SA

Synergy CHC Corp

SANY HEAVY EQUIP INTL HLD by Sany Heavy Equipment International Holdings Co.

Sany Heavy Equipment International Holdings Co Ltd

Synthetify

SUNNYLIFE GLOBAL INC by Sunnylife Global, Inc.

Sunnylife Global Inc

VITAL ENERGY INC (CDA) by Vital Energy, Inc.

Vital Energy Inc

Press Releases

BEYFORTUS® reduced hospital and doctor visits for RSV disease in babies by 87%, according to largest US real-world study

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanofi - SNY

New Report Highlights Community Health Workers' Impact, Calls for Sustained Local Investment, During National CHW Awareness Week

Mandy Moore and Celebrity Mom Squad join Sanofi to help protect babies from RSV with BEYFORTUS®

Sanofi expands patient affordability program by offering access to all its insulins for $35 per month in the US

Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes

ITM Appoints Annette Breunig as Chief People Officer

Contracts

EVOQ Therapeutics Announces Collaboration and License Agreement with Sanofi

Sanofi's high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose

/C O R R E C T I O N -- Sanofi-Aventis Canada Inc./

RVTY

Axsome Therapeutics

AstraZeneca PLC - American Depositary Shares

AstraZeneca

Belite Bio, Inc - American Depositary Shares

Belite Bio

Bristol-Myers Squibb Company Common Stock

Bristol-Myers Squibb

Corcept Therapeutics Incorporated - Common Stock

Corcept Therapeutics

Crinetics Pharmaceuticals, Inc. - Common Stock

Crinetics Pharmaceuticals

Elanco Animal Health Incorporated Common Stock

Elanco Animal Health

GSK plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon

Indivior

Jazz Pharmaceuticals plc - Ordinary Shares

Jazz Pharmaceuticals

Johnson & Johnson

Ligand Pharmaceuticals Incorporated - Common Stock

Ligand Pharmaceuticals

Eli Lilly

Merck & Co

Novo Nordisk

Novartis

Pfizer

Dr. Reddy's Laboratories Ltd Common Stock

Dr Reddy's Laboratories

Regencell Bioscience Holdings Limited - Ordinary Shares

Regencell Bioscience

Royalty Pharma plc - Class A Ordinary Shares

Royalty Pharma

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

Takeda Pharmaceutical Co

Teva Pharmaceutical Industries Limited American Depositary Shares

Teva Pharmaceutical Indus

Viatris

Zoetis

Morgan Stanley

Goldman Sachs

Argus Research

Screenshot 2025-03-12 at 4.47.01 PM

AMGN

BIIB

ELDN

TNXP

Tonix&#39;s TNX-1500 Shows Promise In Preventing Organ Transplant Rejections Of Either Human Or Pig Organs; Autoimmune Diseases Also A Target

Redington 2_29

BDRX

PowerShares Dynamic Financial Sector Portfolio

Comments

Sanofi

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO